PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $35,306 | -13.8% | 13,900 | -36.5% | 0.00% | – |
| Q4 2022 | $40,953 | -61.4% | 21,900 | -47.0% | 0.00% | -100.0% |
| Q3 2022 | $106,000 | +241.9% | 41,300 | +156.5% | 0.00% | – |
| Q2 2022 | $31,000 | -93.8% | 16,100 | -90.5% | 0.00% | -100.0% |
| Q1 2022 | $504,000 | -38.9% | 169,800 | +99.8% | 0.01% | -86.5% |
| Q3 2018 | $825,000 | -5.0% | 85,000 | -0.1% | 0.04% | -21.3% |
| Q2 2018 | $868,000 | -11.0% | 85,100 | +13.5% | 0.05% | -35.6% |
| Q1 2018 | $975,000 | -46.9% | 75,000 | -26.9% | 0.07% | -51.3% |
| Q4 2017 | $1,836,000 | -41.0% | 102,574 | -17.2% | 0.15% | -47.2% |
| Q3 2017 | $3,110,000 | -11.0% | 123,888 | -14.6% | 0.28% | -21.1% |
| Q2 2017 | $3,495,000 | +159.5% | 145,000 | +107.2% | 0.36% | +166.7% |
| Q1 2017 | $1,347,000 | – | 69,983 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |